Institute for Biomedicine - News & Events - Job opportunities
We're starting 2023 with new job positions: we are looking for a Researcher and a PhD Student
Researcher in Neuronal cell biology and physiology
The Institute for Biomedicine at Eurac Research in Bolzano/Bozen is conducting research in the fields of biomedicine, with a focus on neurodegeneration and cardiovascular medicine, integrating genetics and epidemiology data with functional characterization of molecular disease mechanisms with the view to clinical application of research findings.
The Team of Molecular Neurodegeneration investigates cellular and molecular mechanisms underlying the pathogenesis of neurodegenerative and neurological disorders). In 2021 we initiated a project, funded by the Euregio Tyrol-South Tyrol-Trentino, on the study of neurobiological consequences of Covid-19, with the ultimate aim of identifying molecular targets to treat the neurological symptoms of SARS-CoV-2 infection (termed “Neurocovid”). The project is in collaboration with the Medical University of Innsbruck and the Health Service of Trento, for access to patient data.
This position will focus on the differentiation of induced pluripotent stem cells (iPSCs) into cortical neurons, their treatment with Covid-19-relevant material and the investigation of the effects at the neurobiological and neurophysiological levels.
How to apply: Interested candidates should submit their application (CV, cover letter and further relevant documents) by 27 January 2023. https://eurac.onboard.org/jobs/Q4AMJr4Z?from_career_page=true
PhD Student for the HUMAN_DN Project DC7: Computational methods facilitating handling, processing and annotation of metabolomics data and evaluation of variances in blood microsample-based raw MS data
The PhD student will be involved in the development of a software infrastructure for efficient, potential remote, access to large-scale raw MS data, as well as of computational methods facilitating handling, processing and annotation of metabolomics data in a reproducible manner. Integration with existing solutions (such as developed in DC6 and DC8) is a key aspect of the project. In addition, the student will define reproducible analysis workflows and will contribute to the analysis of the blood microsampling-based metabolomics data generated by the consortium.
Eurac Research offers a 3-year PhD position within the HUMAN doctoral network funded under the Horizon2021 Marie Skłodowska-Curie Actions (MSCA) (ID: 101073062). The student will be enrolled in the PhD program of the Friedrich Schiller University Jena (Germany) but is hired by and is expected to work mainly at the Institute for Biomedicine (IfB) of Eurac Research in Bolzano, Italy. The IfB is home to an international and interdisciplinary team of scientists and students integrated in an excellent network of national and international partners. Living and working in Bozen/Bolzano allows to experience a unique combination of alpine and Mediterranean culture right at the heart of one of the most exciting mountain regions in Europe.
The project will involve international and intersectorial secondments/visits to other project partners in the network for the doctoral candidates to learn new skills and foster collaborations. For more information see https://human-dn.eu/
How to apply: Interested candidates should submit their application (CV, cover letter and further relevant documents) by 31 March 2023. https://eurac.onboard.org/jobs/VG8oJW49?from_career_page=true
Other News & Events
La diffusione dell'informazione dalla Ricerca alla pratica medica, alle persone
Due eventi locali organizzati in occasione della giornata mondiale dell’ipertensione.
Ricerca sanitaria: sinergie tra Provincia, Asdaa ed Eurac Research
Azienda Sanitaria, Eurac Research e Amministrazione provinciale promuovono la ricerca sanitaria in Alto Adige.
Kidney biomarkers and cardiovascular risk in South Tyrol population-based studies
We recently published a paper on PLOS ONE journal investigating how we can integrate routinely measured kidney biomarkers to predict cardiovascular risk over 10 years.
New publication on mitochondrial dysfunction and Parkinson's disease
We identified potential presymptomatic molecular markers in clinically non-manifesting heterozygous PRKN variant carriers that could be used to monitor heterozygous PRKN variant carriers during the ...
Our new paper on Parkinson’s disease
We evaluated the neuroprotective role of a novel target against alpha-synuclein neuropathology and elucidated its role in the autophagy-lysosome pathway. We validated the potential of the small GTPase ...
Presentazione ufficiale della nostra nuova sede al NOI Techpark
Siamo operativi nel nuovo laboratorio di circa 900 metri quadrati dove ogni giorno portiamo avanti la nostra Ricerca con l’obiettivo di migliorare le conoscenze sulla salute e sulle malattie.
Identification of genes associated with kidney function and disease
Global characterization of multiple kidney phenotypes through imputation-powered whole-exome analysis.
Investigation of incomplete penetrance in arrhythmogenic cardiomyopathy
Human induced pluripotent stem cell derived cardiomyocytes as a powerful in vitro model